Synopsis: Healthcare Global Enterprises Ltd (HCG) is one of India’s leading oncology-focused healthcare providers with a strong presence across cancer care hospitals and fertility centres. The company continues to expand its advanced healthcare infrastructure and specialised treatment capabilities across India.
Healthcare Global Enterprises Ltd reported steady operational growth in Q4 FY26, driven by higher patient volumes and improved hospital occupancy levels. The company posted double-digit revenue growth on a year-on-year basis along with strong operating profitability. Despite pressure on bottom-line performance due to higher depreciation and finance costs, HCG maintained healthy operational momentum during the quarter.
Healthcare Global Enterprises Ltd currently has a market capitalisation of Rs. 9,723 crore and is trading at Rs. 658 per share up by 1.80% compared to its previous close of Rs. 647. The stock touched a 52-week high of Rs. 800 and a low of Rs. 512.
The company has a stock P/E ratio of 338, while its ROCE and ROE stand at 8.31 percent and 2.55 percent respectively. The company operates in India’s rapidly expanding healthcare and oncology services sector.
Healthcare Global Enterprises reported revenue of Rs. 652.33 crore in Q4 FY26, compared to Rs. 585.16 crore in Q4 FY25, registering a year-on-year growth of around 11.5 percent. On a sequential basis, revenue also increased from Rs. 633.07 crore reported in Q3 FY26. Operating profit rose to Rs. 125.08 crore in Q4 FY26 from Rs. 105.63 crore in the corresponding quarter last year, reflecting a growth of nearly 18.4 percent YoY.
The company’s operating margin improved to 19.17 percent during the quarter compared to 18.05 percent in Q4 FY25, indicating better operational efficiency. Profit before tax stood at Rs. 1.25 crore in Q4 FY26 compared to Rs. 13.62 crore in the year-ago period, impacted by higher depreciation and finance expenses.
Net profit came in at Rs. 4.04 crore during the quarter against Rs. 6.77 crore reported in Q4 FY25, while sequentially the company returned to profitability from a loss of Rs. 7.90 crore reported in Q3 FY26.
Industry Outlook
India’s healthcare sector continues to witness strong structural growth supported by rising healthcare spending, increasing insurance penetration, and growing demand for specialised medical services.
The government has allocated Rs. 99,858 crore to the healthcare sector in Union Budget FY26, reflecting a nearly 9.8 percent increase compared to the previous year. The country is also expected to require nearly 3 million additional hospital beds by 2025 to meet growing healthcare demand.
Private equity investments in Indian healthcare touched Rs. 4,900 crore across 33 deals in Q2 CY25, highlighting strong investor confidence in the sector. India’s healthcare workforce has already crossed 6 million professionals and is expected to expand significantly by 2030.
Rising cancer incidence, increasing adoption of advanced treatments, and expansion of multi-speciality healthcare infrastructure are expected to create long-term growth opportunities for hospital chains like HCG.
Healthcare Global Enterprises delivered steady revenue and operating profit growth during Q4 FY26, supported by improving operational performance and rising healthcare demand. While profitability remained under pressure due to higher costs, the company’s strong focus on oncology care and hospital expansion positions it well for long-term growth.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Healthcare Global Enterprises Shares In Spotlight After Q4 Revenue Rises 11% YoY appeared first on Trade Brains.